Atom Investors’s Clene CLNN Stock Holding History

Atom Investors’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,153	Closed	-$123K	–	259
2022 Q4	$123K	Buy	+6,153	New	+$143K	0.06%	190

Other funds holding CLNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.33B AUM 19.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Atom Investors's CLNN Position: Q1 2023 in Review

Atom Investors sold out of Clene (CLNN) in Q1 2023, closing a stake of 6,153 shares — an estimated $123K sold.

Atom Investors first reported a position in CLNN in Q4 2022 and held it in 1 quarter. The position peaked at $123K in Q4 2022. 31 funds tracked by Wall St. Rank hold CLNN as of Q1 2023.

Atom Investors reported no remaining Clene position as of Q1 2023 after selling out during the quarter.
Atom Investors sold 6,153 Clene shares in Q1 2023, an estimated $123K.
Atom Investors first reported a position in Clene in Q4 2022 and held it in 1 quarter.
Atom Investors's Clene position peaked at $123K in Q4 2022.
31 funds tracked by Wall St. Rank held Clene as of Q1 2023.

Based on Atom Investors's 13F filing for Q1 2023, filed 15 May 2023.